94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
by Thomsen AR, Sahlmann J, Bronsert P, Schilling O, Poensgen F, May AM, Timme-Bronsert S, Grosu A-L, Vaupel P, Gebbers J-O, Multhoff G and Lüchtenborg A-M (2023). Front. Oncol. 13:1275222. doi: 10.3389/fonc.2023.1275222
Due to a production error, the incorrect affiliation was assigned to Andreas R. Thomsen, Oliver Schilling, Sylvia Timme-Bronsert, Anca-Ligia Grosu, Peter Vaupe, and Anne-Marie Lüchtenborg. The corrected author list and affiliations are listed below.
Andreas R. Thomsen1,2, Jörg Sahlmann3, Peter Bronsert4,5
Oliver Schilling2,5, Felicia Poensgen1,6, Annette M. May5,7
Sylvia Timme-Bronsert2,5, Anca-Ligia Grosu1,2, Peter Vaupel1,2,
Jan-Olaf Gebbers8, Gabriele Multhoff 9
and Anne-Marie Lüchtenborg1,2*
1Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2German Cancer Consortium (DKTK), Partner Site DKTK-Freiburg, Freiburg, Germany,
3 Institute for Medical Biometry and Statistics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
4Tumobank Comprehensive Cancer Center Freiburg, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
5Institute for Surgical Pathology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
6Pediatric Department, Black Forest Baar Clinic, Villingen-Schwenningen, Germany
7Medizinisches Versorgungszentrum Laaff, Freiburg, Germany
8Department of Pathology, Working Group Digital Pathology, University of Berne, Bern, Switzerland
9Center for Translational Cancer Research, Klinikum rechts der Isar, Department of Radiation Oncology, Technical University Munich (TUM), Munich, Germany
The publisher apologizes for this mistake.
The original version of this article has been updated.
Keywords: breast cancer, hypofractionated radiotherapy, hyperthermia, predictive markers, longitudinal study, regression, recurrent breast cancer, re-irradiation
Citation: Frontiers Production Office (2024) Erratum: Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer. Front. Oncol. 14:1414294. doi: 10.3389/fonc.2024.1414294
Received: 08 April 2024; Accepted: 08 April 2024;
Published: 19 April 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn